BMS-833923 (XL139)

BMS-833923 · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BMS-833923 (XL139), covering 2013-06-03 to 2014-08-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer [Phase 1]